Cart (0 Items)
Your cart is currently empty.
View Products 
               
               
               
              | Size | 100ug, 1MG | 
|---|---|
| Isotype | IgG1, kappa | 
| Brand | ProteoGenix | 
| Product type | Primary Antibodies | 
| Clonality | Monoclonal Antibody | 
| Expression system | Mammalian cells | 
| Applications | Elisa, WB | 
| Product name | Risankizumab Biosimilar - Anti-IL23A mAb - Research Grade | 
|---|---|
| Source | CAS 1612838-76-2 | 
| Species | Humanized | 
| Expression system | Mammalian cells | 
| Purity | >85% | 
| Buffer | PBS buffer PH7.5 | 
| Delivery condition | Blue ice (+4°C) | 
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed | 
| Storage condition | store at -80°C | 
| Brand | ProteoGenix | 
| Aliases /Synonyms | Risankizumab,BI 655066,risankizumab-rzaa,IL23A,anti-IL23A | 
| Reference | PX-TA1396 | 
| Note | For research use only. Not suitable for clinical or therapeutic use. | 
| Isotype | IgG1-kappa | 
| Clonality | Monoclonal Antibody | 
Risankizumab is a humanized IgG1 monoclonal antibody (mAb) that targets interleukin 23 (IL-23). It has been used for the treatment of moderate-to-severe plaque psoriasis
 
                Risankizumab Biosimilar - Anti-IL23A mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.